^
BIOMARKER:
KRAS G12D
i
Other names: KRAS, KRAS1, KRAS2, Kirsten rat sarcoma viral oncogene homolog
Entrez ID:
Related biomarkers:
KRAS G12D
CRC
bevacizumab + PCM-075
Sensitive
:
C3
Cardiff Oncology Press Release - 3wk
KRAS G12D
CRC
cetuximab
Resistant
:
B
KRAS G12D
CRC
panitumumab
Resistant
:
B
KRAS G12D
NSCLC
osimertinib
Resistant
:
C3
KRAS G12D
CRC
cobimetinib + SAR442720
Sensitive
:
C3
KRAS G12D
Ovarian Serous Adenocarcinoma
VS-6766 + VS-6063
Sensitive
:
C3
KRAS G12D
Biliary Tract Cancer
selumetinib
Sensitive
:
C3
KRAS G12D
HCC
sorafenib + BAY86-9766
Sensitive
:
C3
KRAS G12D
Pancreatic Cancer
entrectinib
Sensitive
:
C3
KRAS G12D
Pancreatic Cancer
ASTX029
Sensitive
:
C3
KRAS G12D
Gallbladder Cancer
pembrolizumab
Sensitive
:
C4
KRAS G12D
CRC
regorafenib
Sensitive
:
C4
KRAS G12D
Pancreatic Cancer
MK-2206
Sensitive
:
C4
KRAS G12D
Lung Cancer
KS-58
Sensitive
:
D
KRAS G12D
NSCLC
IPI-504
Sensitive
:
D
KRAS G12D
Pancreatic Cancer
KS-58
Sensitive
:
D
KRAS G12D
CRC
MRTX1133
Sensitive
:
D
KRAS G12D
Pancreatic Cancer
MRTX1133
Sensitive
:
D
KRAS G12D
Pancreatic Cancer
BCN057
Sensitive
:
D
KRAS G12D
Cholangiocarcinoma
ponatinib
Sensitive
:
D
KRAS G12D
Cholangiocarcinoma
bosutinib
Sensitive
:
D
KRAS G12D
Cholangiocarcinoma
AZD0530
Sensitive
:
D
KRAS G12D
Cholangiocarcinoma
dasatinib
Sensitive
:
D
KRAS G12D
Ovarian Cancer
PD-0325901 + PF-04691502
Sensitive
:
D
KRAS G12D
Ovarian Cancer
PF-04691502
Sensitive
:
D
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our